← Eichor
Condition: Acute Myeloid Leukemias Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Acute Myeloid Leukemias

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Haplo-Cord HSCT for AML/MDS
NA · 4 location(s) · Fujian Medical University Union Hospital · NCT07588360OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
Phase N/A · 21 location(s) · French Innovative Leukemia Organisation · NCT06377579Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Phase 1/Phase 2 · 1 location(s) · Zhujiang Hospital · NCT05270200Massage Impact on Sleep in Pediatric Oncology
NA · 2 location(s) · Children's Hospital of Philadelphia · NCT06892158Romiplostim N01 for Platelet Recovery After Haploidentical HSCT
Phase 1 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07321626Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06529250A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Phase 1 · 53 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT04227847Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06769490Phase I Study of HC-7366 for Acute Myeloid Leukemia
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06285890Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HS
Phase N/A · 1 location(s) · Ciceri Fabio · NCT05124288A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in
Phase 1 · 2 location(s) · Mayo Clinic · NCT03017820Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Phase 2 · 9 location(s) · Bio-Path Holdings, Inc. · NCT02781883A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07500753Novel Digital Application for Patients With Acute Leukemia
NA · 3 location(s) · Massachusetts General Hospital · NCT06472128A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia:
Phase 1/Phase 2 · 2 location(s) · Jacqueline Garcia, MD · NCT07148180Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Phase N/A · 3 location(s) · Mayo Clinic · NCT06279572Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute
Phase 1 · 10 location(s) · St. Jude Children's Research Hospital · NCT06177067Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Based DCMG Regimen for R/R AML
Phase 2 · 1 location(s) · Beijing 302 Hospital · NCT06741722Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and
Phase 1/Phase 2 · 26 location(s) · Sellas Life Sciences Group · NCT04588922A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06763341Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Mye
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT07094750Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06394011Olverembatinib for FGFR1-rearranged Neoplasms
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT05521204Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological M
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04195633Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia
Phase 1 · 2 location(s) · University Hospital, Antwerp · NCT05506332A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Pa
Phase 1 · 3 location(s) · City of Hope Medical Center · NCT07020533Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling,
Phase N/A · 28 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05772559Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated
Phase 1 · 23 location(s) · Lomond Therapeutics Holdings, Inc. · NCT06366789
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.